tiprankstipranks
Trending News
More News >

Julius Knowles Insider Profile

4 Followers
Julius Knowles, Director at Keros Therapeutics, holds 580.74K shares in Keros Therapeutics (Ticker: KROS).
tipranks
Julius Knowles

Julius Knowles
Keros Therapeutics (KROS)
Director

Not Ranked
Julius Knowles has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
100.00%
A breakdown of Julius Knowles's holdings

Insider Roles

Keros Therapeutics
(KROS)
Director
Roles that Julius Knowles holds in companies

Most Profitable Insider Trade

Stock:
Keros Therapeutics
(KROS)
Rating:Informative Buy
Date:Jan 20, 2023 - Jan 20, 2024
Return:+4.70%
The most profitable trade made by Julius Knowles

Julius Knowles's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Keros Therapeutics
Jun 06, 2025
Director
Uninformative Buy
$8.03M
Success Rate for
KROS
1 out of 1 profitable transactions on
KROS
100%
Average Return for
KROS
Average return per transaction on
KROS
+4.70%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Apr 13, 2020
Uninformative Buy
$0.00
-
$0.00
Jan 20, 2023
Informative Buy
$24.99K
-
$20.98
+4.70%
Jun 06, 2025
Uninformative Buy
$0.00
-
$0.00
Feb 16, 2021
Uninformative Sell
$1.21M
-
$63.53
Feb 18, 2021
Uninformative Sell
$1.74M
-
$60.87
List of latest transactions for each holding click on a transaction to see Julius Knowles's performance on stock

Julius Knowles insider profile FAQ

What is the percentage of profitable transactions made by Julius Knowles?
The percentage of profitable transactions made by Julius Knowles is ―.
    What is the average return per transaction made by Julius Knowles?
    The average return per transaction made by Julius Knowles is ―.
      What stocks does Julius Knowles hold?
      Julius Knowles holds: KROS stocks.
        What was Julius Knowles’s latest transaction?
        Julius Knowles latest transaction was an Uninformative Buy of ―.
          What was Julius Knowles's most profitable transaction?
          Julius Knowles’s most profitable transaction was an Informative Buy of KROS stock on January 20, 2023. The return on the trade was 4.70%.
            What is Julius Knowles's role in Keros Therapeutics?
            Julius Knowles's role in Keros Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.